Trials / Completed
CompletedNCT03045445
"Double Low-Dose" DECT for HCC Imaging
Comparison of Image Quality Between "Double Low-Dose" Dual Energy Liver CT and Standard Contrast Enhanced Liver CT in Patients at High-risk of HCC: Prospective, Randomized Single Center Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis: double low-dose protocol provide better lesion conspicuity than standard protocol CT in patients at high-risk of HCC. patients who are scheduled for CECT for HCC diagnosis or surveillance are eligible for this study and allocated to either standard protocol or double-low dose protocol using spectral CT with low radiation dose and low dose of contrast media, within clinically accpetable range.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Double Low-Dose protocol CT | Double low-dose protocol CT (Low radiation dose quadriphasic liver CT and low dose of iodine contrast media) at spectral dual energy CT scanner |
| DIAGNOSTIC_TEST | Standard protocol CT | standard protocol CT (standard dose quadriphasic liver CT and standard dose of iodine contrast media) at spectral dual energy CT scanner |
Timeline
- Start date
- 2017-05-30
- Primary completion
- 2018-03-21
- Completion
- 2019-09-25
- First posted
- 2017-02-07
- Last updated
- 2021-03-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03045445. Inclusion in this directory is not an endorsement.